The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia (Q43041881)

12 November 2017

title

The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia (English)

1 reference

12 November 2017

0 references

2

1 reference

12 November 2017

Yao F

1

1 reference

12 November 2017

Farrugia A

3

1 reference

12 November 2017

Morgan D

4

1 reference

12 November 2017

Cordner S

5

1 reference

12 November 2017

Wood D

6

1 reference

12 November 2017

Zheng MH

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

American Journal of Transplantation

12 November 2017

published in

1 reference

12 November 2017

volume

7

1 reference

12 November 2017

issue

12

1 reference

12 November 2017

page(s)

2723-2726

1 reference

Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

International application of the incidence rate/window period model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Comparison of prevalence rates of microbiological markers between bone/tissue donations and new blood donors in Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Assessing the impact of HBV NAT on window period reduction and residual risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992-1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

HIV and hepatitis C virus RNA in seronegative organ and tissue donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02012.X

10.1111/J.1600-6143.2007.02012.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference